Kenvue Inc. (NYSE:KVUE) Stock Holdings Raised by Yacktman Asset Management LP

Yacktman Asset Management LP lifted its stake in shares of Kenvue Inc. (NYSE:KVUE) by 43.3% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 5,409,457 shares of the company’s stock after purchasing an additional 1,635,395 shares during the period. Yacktman Asset Management LP’s holdings in Kenvue were worth $116,466,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of KVUE. Beaumont Financial Advisors LLC lifted its holdings in Kenvue by 3.0% during the 4th quarter. Beaumont Financial Advisors LLC now owns 17,532 shares of the company’s stock worth $377,000 after buying an additional 509 shares during the last quarter. Pinnacle Bancorp Inc. boosted its holdings in Kenvue by 51.3% in the fourth quarter. Pinnacle Bancorp Inc. now owns 1,552 shares of the company’s stock worth $33,000 after purchasing an additional 526 shares during the period. Dfpg Investments LLC increased its stake in Kenvue by 2.3% during the fourth quarter. Dfpg Investments LLC now owns 26,659 shares of the company’s stock valued at $567,000 after purchasing an additional 589 shares during the last quarter. Mutual Advisors LLC raised its holdings in shares of Kenvue by 6.1% during the fourth quarter. Mutual Advisors LLC now owns 10,606 shares of the company’s stock worth $228,000 after purchasing an additional 612 shares during the period. Finally, Baron Wealth Management LLC lifted its position in shares of Kenvue by 7.5% in the 4th quarter. Baron Wealth Management LLC now owns 12,915 shares of the company’s stock worth $278,000 after buying an additional 899 shares during the last quarter. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the stock. Royal Bank of Canada lowered their price objective on shares of Kenvue from $25.00 to $24.00 and set an “outperform” rating for the company in a research report on Friday, February 9th. Sanford C. Bernstein started coverage on Kenvue in a research report on Thursday, April 11th. They set an “underperform” rating and a $18.00 price target on the stock. The Goldman Sachs Group assumed coverage on Kenvue in a research report on Friday, March 1st. They set a “neutral” rating and a $20.00 price objective for the company. William Blair assumed coverage on Kenvue in a research report on Wednesday, April 3rd. They issued a “market perform” rating on the stock. Finally, JPMorgan Chase & Co. reduced their price target on shares of Kenvue from $25.00 to $24.00 and set an “overweight” rating for the company in a report on Friday, February 9th. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and seven have given a buy rating to the company. According to MarketBeat, Kenvue has an average rating of “Hold” and an average price target of $24.85.

Kenvue Stock Performance

Shares of Kenvue stock traded down $0.07 on Friday, hitting $18.95. The company had a trading volume of 9,264,053 shares, compared to its average volume of 16,609,451. Kenvue Inc. has a 52 week low of $17.82 and a 52 week high of $27.80. The company has a current ratio of 1.12, a quick ratio of 0.78 and a debt-to-equity ratio of 0.69. The business has a 50-day simple moving average of $19.84 and a 200-day simple moving average of $20.14.

Kenvue (NYSE:KVUE) last issued its quarterly earnings results on Thursday, February 8th. The company reported $0.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.28 by $0.03. The firm had revenue of $3.67 billion during the quarter, compared to analyst estimates of $3.78 billion. Kenvue had a return on equity of 15.62% and a net margin of 9.87%. The firm’s revenue was down 2.7% on a year-over-year basis. As a group, sell-side analysts anticipate that Kenvue Inc. will post 1.15 EPS for the current year.

Kenvue Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 22nd. Stockholders of record on Wednesday, May 8th will be given a dividend of $0.20 per share. The ex-dividend date of this dividend is Tuesday, May 7th. This represents a $0.80 annualized dividend and a dividend yield of 4.22%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.